Not applicableLooking for participantsNCT04517838
What this trial is testing
Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer
Who this might be right for
Breast AdenocarcinomaHER2-Positive Breast CarcinomaAnatomic Stage I Breast Cancer AJCC v8+3 more
Mayo Clinic 230